Lessons from the human embryo debate  by Williams, Nigel
British members of parliament voted
last month decisively to relax the
rules governing the controversial
move into research on stem cells
derived from human embryos,
despite warnings by critics that the
move would endorse techniques that
could be used in human cloning.
The cells in question are human
embryonic stem cells, up to 100 of
which make up the embryo in its
first few days after conception.
Researchers want to see if they can
persuade them to grow into
replacement components for people
whose original cells have failed: to
replace nerve cells, for instance, in
the brains of Parkinson’s disease
sufferers. But some work will involve
replacement of the embryonic cell
nuclei with adult nuclei, raising fears
among critics of the prospect of
human cloning.
After unusually lengthy
discussions comprising three
separate debates, MPs agreed in a
free vote to endorse the new
regulations by a majority of almost 2
to 1. The move puts Britain in the
vanguard of legislation in this field
and offers lessons to bodies in other
countries grappling with these issues.
Support for the new regulations
has been built on several fronts.
Firstly, and most importantly, the
principle of human embryo research
was endorsed 11 years ago in the
Human Fertilisation and
Embryology Act. Under current law,
research can be carried out on
embryos up to 14 days old but each
experiment must be licensed by the
Human Fertilisation and
Embryology Authority (HFEA). This
body must be satisfied that there is
no other way of doing the research
without using embryos. The
embryos must also be donated
through informed consent.
At present research can only be
done for one of five purposes:
advances in the treatment of
infertility, increasing knowledge
about congenital diseases, increasing
knowledge about the causes of
miscarriage, developing more
effective contraceptives or
developing methods for detecting
gene and chromosome abnormalities
before implantation.
“Many people do not feel that they
can, as a matter of conscience,
turn their backs on research”
All the new regulations do “is
change the purpose of the permitted
research to include basic research
into stem cells and research into the
understanding and treatment of
serious disease,” said health minister,
Yvette Cooper. “The strict regulatory
framework that exists for embryo
research right now will apply also to
the new research,” she said.
But many people are uneasy at
any expansion in embryo research.
Several MPs argued for greater
attention to be paid to the potential
in stem cells that can be derived
from adults as a more acceptable
research tool. But supporters said
that wide and open consultation
within the research community
pointed to the belief that embryo-
derived cells at present offer the best
potential. But if a breakthrough
makes adult cells viable, the HFEA
is already able to refuse licenses for
embryo work, Ms Cooper said. The
14-day cut-off for work with intact
embryos remains and implantation of
embryos created through nuclei
replacement is still illegal.
Supporters of the new regulations
have been skilful in focusing the
detailed debate on issues of broad
concern while acknowledging that
some people remain vehemently
opposed to any research on human
embryos at all. Ministers had
published draft changes and
modified them in the light of some
concerns expressed, Ms Cooper said.
While taking care not to
exaggerate the prospect of early
progress,  she believed that “many
people do not feel that they can, as a
mattter of conscience, turn their
backs on research that could relieve
the suffering of so many”.
But some of the strongest support
for the new regulations came from
MPs closest to some of the diseases
the new research may address. Anne
Campbell said that her mother and
two aunts had suffered from
Parkinson’s disease. “I consider that
I am very vulnerable and I want to
be certain that when or if I ever
develop symptoms of Parkinson’s
then there will be some hope of
some cure,” she said.
Fiona Mactaggart suffers from
multiple sclerosis, and has been
unable to have children. “At the
moment there are two fertilised
embryos of mine in a medical facility,
which are available for research,” she
said. “It is ironic that they could be
used in research that could help to
deal with my infertility and not to be
used in research which could be of
help to deal with the thing about
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which I am more anxious, my
multiple sclerosis. Unless we pass
these regulations that will be the
case for everybody.”
After the vote, pro-change
campaigners, including the
wheelchair-using MP Anne Begg,
expressed their delight at the
outcome. Robert Meadowcroft,
director of policy and research at the
Parkinson’s Disease Society, said:
“This vote offers tremendous hope
to people with Parkinson’'s. Stem
cell research has the potential to lead
to improved treatments, and maybe
even a cure, and support for these
regulations is the first step to
realising that potential.”
Mike Dexter, director of the
Wellcome Trust, said: “This is a vote
for science, for health, and for the
future. The priority now must be to
take forward the research and deliver
real health benefits.”
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